Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis: Correction

Nidhi S Dey; Sujai Senaratne; Vijani Somaratne; Nayani P Madarasinghe; Bimalka Seneviratne; Sarah Forrester; Marcela Montes de Oca; Luiza Campos Reis; Srija Moulik; Pegine B Walrad; Mitali Chatterjee; Hiro Goto; Renu Wickremasinghe; Dimitris Lagos; Paul M Kaye; Shalindra Ranasinghe

doi:10.1172/JCI180162

Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis: Correction

Nidhi S Dey, Sujai Senaratne, Vijani Somaratne, Nayani P Madarasinghe, Bimalka Seneviratne, Sarah Forrester, Marcela Montes de Oca, Luiza Campos Reis, Srija Moulik, Pegine B Walrad, Mitali Chatterjee, Hiro Goto, Renu Wickremasinghe, Dimitris Lagos, Paul M Kaye, Shalindra Ranasinghe

Research output: Contribution to journal › Article

Original language	English
Article number	e180162
Number of pages	1
Journal	Journal of Clinical Investigation
Volume	134
Issue number	5
DOIs	https://doi.org/10.1172/JCI180162
Publication status	Published - 1 Mar 2024

Keywords

Humans
B7-H1 Antigen/genetics
Leishmaniasis, Cutaneous/drug therapy
Skin Neoplasms/metabolism

Access to Document

10.1172/JCI180162Licence: CC BY

Cite this

Dey, N. S., Senaratne, S., Somaratne, V., Madarasinghe, N. P., Seneviratne, B., Forrester, S., Montes de Oca, M., Reis, L. C., Moulik, S., Walrad, P. B., Chatterjee, M., Goto, H., Wickremasinghe, R., Lagos, D., Kaye, P. M., & Ranasinghe, S. (2024). Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis: Correction. Journal of Clinical Investigation, 134(5), Article e180162. https://doi.org/10.1172/JCI180162

@article{57e31c58e52a41b1a923335013dcb234,

title = "Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis: Correction",

keywords = "Humans, B7-H1 Antigen/genetics, Leishmaniasis, Cutaneous/drug therapy, Skin Neoplasms/metabolism",

author = "Dey, {Nidhi S} and Sujai Senaratne and Vijani Somaratne and Madarasinghe, {Nayani P} and Bimalka Seneviratne and Sarah Forrester and {Montes de Oca}, Marcela and Reis, {Luiza Campos} and Srija Moulik and Walrad, {Pegine B} and Mitali Chatterjee and Hiro Goto and Renu Wickremasinghe and Dimitris Lagos and Kaye, {Paul M} and Shalindra Ranasinghe",

year = "2024",

month = mar,

day = "1",

doi = "10.1172/JCI180162",

language = "English",

volume = "134",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "The American Society for Clinical Investigation",

number = "5",

}

Dey, NS, Senaratne, S, Somaratne, V, Madarasinghe, NP, Seneviratne, B, Forrester, S , Montes de Oca, M, Reis, LC, Moulik, S, Walrad, PB, Chatterjee, M, Goto, H, Wickremasinghe, R, Lagos, D , Kaye, PM & Ranasinghe, S 2024, 'Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis: Correction', Journal of Clinical Investigation, vol. 134, no. 5, e180162. https://doi.org/10.1172/JCI180162

TY - JOUR

T1 - Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis

T2 - Correction

AU - Dey, Nidhi S

AU - Senaratne, Sujai

AU - Somaratne, Vijani

AU - Madarasinghe, Nayani P

AU - Seneviratne, Bimalka

AU - Forrester, Sarah

AU - Montes de Oca, Marcela

AU - Reis, Luiza Campos

AU - Moulik, Srija

AU - Walrad, Pegine B

AU - Chatterjee, Mitali

AU - Goto, Hiro

AU - Wickremasinghe, Renu

AU - Lagos, Dimitris

AU - Kaye, Paul M

AU - Ranasinghe, Shalindra

PY - 2024/3/1

Y1 - 2024/3/1

KW - Humans

KW - B7-H1 Antigen/genetics

KW - Leishmaniasis, Cutaneous/drug therapy

KW - Skin Neoplasms/metabolism

U2 - 10.1172/JCI180162

DO - 10.1172/JCI180162

M3 - Article

C2 - 38426499

SN - 0021-9738

VL - 134

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 5

M1 - e180162

ER -